Pharma Mar SA ( (ES:PHM) ) has issued an announcement.
Pharma Mar, S.A. has announced the execution of a Share Delivery Plan aimed at employees and executives, excluding board members, to encourage participation in the company’s share capital and incentivize retention. The plan involves delivering up to 41,000 shares from treasury stock, with a total value of 832,553.87 euros, and includes a lock-up period of three years, partially lifting after 18 months. This initiative is expected to strengthen employee commitment and align interests with the company’s long-term goals.
More about Pharma Mar SA
Pharma Mar, S.A. is a company operating in the pharmaceutical industry, focusing on the development and commercialization of marine-derived drugs. The company is engaged in the research and production of oncology and central nervous system therapies, with a market focus on innovative treatments derived from marine organisms.
YTD Price Performance: 6.14%
Average Trading Volume: 1,304
Technical Sentiment Signal: Sell
Current Market Cap: $1.58B
See more insights into PHM stock on TipRanks’ Stock Analysis page.